Scientific Online Resource System

Annual for Hospital Pharmacy

Arterial hypertension and cerebrovascular disease

Ivan Gruev, Silvia Tsanova-Savova

Abstract

Arterial hypertension is the most important risk factor for development of cerebrovascular disease and stroke in particular. That is why the most accurate marker for the level of control of hypertension is stroke mortality and morbidity.

Keywords

arterial hypertension; cerebrovascular disease stroke

Full Text


References

World Health Organization. World Health statistics 2014 [Internet]. World Health Organization. 2014. 180 p. Available from: http://www.who.int/mediacentre/news/releases/2014/ world-health-statistics-2014/en/

Messerli FH, Williams B, Ritz E. Essential hypertension. Lancet (London, England). 2007 Aug;370(9587):591–603.

Report TS. Prevention , Detection , Evaluation , and Treatment of. Blood Press [Internet]. 2003;289(19):1206–52. Available from: http://hyper.ahajournals.org/content/42/6/1206.short

Гочева Н, Аврамов Д. Комбинирано лечение на артериал- ната хипертония. MEDINFO. 2007;(3):1–5.

Григоров Е, Лебанова Х, Насева Е, Гетов И. Проучване на нагласите за измерване на кръвно налягане сред посети- телите в аптеки в София. Сърдечно-съдови заболявания. 2012;43(2):43–7.

Grigorov E, Naseva E, Lebanova H, Getov I. Testing willingness to pay for blood pressure measurement in community pharmacy. African J Pharm Pharmacol. 2012;6(13):1005–10.

Peila R, White LR, Masaki K, Petrovitch H, Launer LJ. Reducing the risk of dementia: efficacy of long-term treatment of hypertension. Stroke. 2006 May;37(5):1165–70.

Dahlof B. Prevention of stroke in patients with hypertension. Am J Cardiol. 2007 Aug;100(3A):17J–24J.

Palmer AJ, Bulpitt CJ, Fletcher AE, Beevers DG, Coles EC, Ledingham JG, et al. Relation between blood pressure and stroke mortality. Hypertens (Dallas, Tex 1979). 1992 Nov;20(5):601–5.

Веков Т. Международният и български опит в областта на инвазивната и интервенционална кардиология – раз- витие, необходимост, резултати. Сърдечно-съдови забо- лявания. 2009;40(1):22–6.

Стаменова П. Световен ден за борба с инсулта - 29 октом- ври [Internet]. Available from: http://www.mh.government. bg/bg/informaciya-za-grazhdani/svetovni-zdravni-dni/ svetoven-den-za-borba-s-insulta-29-oktomvri/

Potter JF, Robinson TG, Ford GA, Mistri A, James M, Chernova J, et al. Controlling hypertension and hypotension immediately post-stroke (CHHIPS): a randomised, placebocontrolled, double-blind pilot trial. Lancet Neurol. 2009 Jan;8(1):48–56.

Schrader J, Lüders S, Kulschewski A, Berger J, Zidek W, Treib J, et al. The ACCESS study: Evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors. Stroke. 2003;34(7):1699–703.

Sandset EC, Bath PMW, Boysen G, Jatuzis D, Korv J, Luders S, et al. The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebocontrolled, double-blind trial. Lancet (London, England). 2011 Feb;377(9767):741–50.

Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension. Eur Heart J [Internet]. 2013 Jul 21;34(28):2159 LP-2219. Available from: http://eurheartj.oxfordjournals.org/ content/34/28/2159.abstract

Янева-Сиракова Т, Търновска –Къдрева Р, Трайков Л. Зна- чения на централното аортно налягане за дисфункция на малките съдове и развитието на когнитивни нарушения. Българска неврология. 2012;12(1):21–6.


Refbacks

Article Tools
Email this article (Login required)